On the public citation graph

Mitoxantrone modulates a heparan sulfate-spike complex to inhibit SARS-CoV-2 infection

0 signed · 62 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/j.antiviral.2020.104873openalex-snapshot
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions
inferredcites →https://doi.org/10.1016/j.cell.2020.02.052openalex-snapshot
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
inferredcites →https://doi.org/10.1016/j.cell.2020.02.058openalex-snapshot
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
inferredcites →https://doi.org/10.1016/j.cell.2020.09.033openalex-snapshot
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
inferredcites →https://doi.org/10.1016/j.clim.2020.108634openalex-snapshot
COVID-19: A review of therapeutic strategies and vaccine candidates
inferredcites →https://doi.org/10.1016/j.drup.2020.100721openalex-snapshot
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses
inferredcites →https://doi.org/10.1016/j.drup.2020.100733openalex-snapshot
COVID-19 update: The race to therapeutic development
inferredcites →https://doi.org/10.1016/s0140-6736(21)00947-8openalex-snapshot
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
inferredcites →https://doi.org/10.1016/s1473-3099(21)00558-2openalex-snapshot
Hospitalisation among vaccine breakthrough COVID-19 infections
inferredcites →https://doi.org/10.1016/s2352-3018(14)70027-xopenalex-snapshot
Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trial
inferredcites →https://doi.org/10.1021/acscentsci.1c00010openalex-snapshot
Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2
inferredcites →https://doi.org/10.1038/d41573-020-00151-8openalex-snapshot
Evolution of the COVID-19 vaccine development landscape
inferredcites →https://doi.org/10.1038/s41392-020-0184-0openalex-snapshot
The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin
inferredcites →https://doi.org/10.1038/s41421-020-00222-5openalex-snapshot
Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro
inferredcites →https://doi.org/10.1038/s41422-020-00460-yopenalex-snapshot
AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells
inferredcites →https://doi.org/10.1038/s41467-020-15562-9openalex-snapshot
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
inferredcites →https://doi.org/10.1038/s41467-020-17796-zopenalex-snapshot
Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells
inferredcites →https://doi.org/10.1038/s41586-021-03676-zopenalex-snapshot
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants
inferredcites →https://doi.org/10.1038/s41594-020-0469-6openalex-snapshot
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
inferredcites →https://doi.org/10.1038/s42003-022-03753-7openalex-snapshot
Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents
inferredcites →https://doi.org/10.1055/s-0040-1721319openalex-snapshot
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin
inferredcites →https://doi.org/10.1056/nejmoa2007764openalex-snapshot
Remdesivir for the Treatment of Covid-19 — Final Report
inferredcites →https://doi.org/10.1073/pnas.0809524106openalex-snapshot
Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites
inferredcites →https://doi.org/10.1073/pnas.1918617117openalex-snapshot
A myosin-7B–dependent endocytosis pathway mediates cellular entry of α-synuclein fibrils and polycation-bearing cargos
inferredcites →https://doi.org/10.1073/pnas.2003138117openalex-snapshot
Cell entry mechanisms of SARS-CoV-2
inferredcites →https://doi.org/10.1093/nar/gkt828openalex-snapshot
On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs
inferredcites →https://doi.org/10.1093/protein/8.2.127openalex-snapshot
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
inferredcites →https://doi.org/10.1101/2020.10.08.331751openalex-snapshot
Preferential recognition and antagonism of SARS-CoV-2 spike glycoprotein binding to 3- O -sulfated heparan sulfate
inferredcites →https://doi.org/10.1101/cshperspect.a004952openalex-snapshot
Heparan Sulfate Proteoglycans
inferredcites →https://doi.org/10.1111/febs.15369openalex-snapshot
Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing
inferredcites →https://doi.org/10.1126/science.abd2985openalex-snapshot
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
inferredcites →https://doi.org/10.1126/science.abd3072openalex-snapshot
Neuropilin-1 is a host factor for SARS-CoV-2 infection
inferredcites →https://doi.org/10.1126/science.abe4747openalex-snapshot
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
inferredcites →https://doi.org/10.1126/science.abe6230openalex-snapshot
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
inferredcites →https://doi.org/10.1128/jvi.00127-20openalex-snapshot
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus
inferredcites →https://doi.org/10.1128/jvi.01987-20openalex-snapshot
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives
inferredcites →https://doi.org/10.1128/jvi.02438-20openalex-snapshot
Potent Neutralization of SARS-CoV-2 by Hetero-Bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain
inferredcites →https://doi.org/10.1371/journal.ppat.1009246openalex-snapshot
Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion
inferredcites →https://doi.org/10.3389/fmolb.2021.649575openalex-snapshot
Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer
inferredcites →https://doi.org/10.7554/elife.61390openalex-snapshot
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.3897/pharmacia.72.e141634zenodo-depositor-declared
Inhibition of MERS-CoV papain-like protease by sunitinib: In vitro and in silico investigations
inferred← citeshttps://doi.org/10.1002/jmv.70888openalex-snapshot
The Diverse Roles of Heparan Sulfate in RNA Virus Infections: Insights From Enterovirus A71, Severe Acute Respiratory Syndrome Coronavirus 2, and Chikungunya Virus
inferred← citeshttps://doi.org/10.1007/s12033-024-01240-4openalex-snapshot
Prospects of Innovative Therapeutics in Combating the COVID-19 Pandemic
inferred← citeshttps://doi.org/10.1016/j.eurpolymj.2023.112452openalex-snapshot
Anionic and cationic block copolymers as promising modulators of blood coagulation
inferred← citeshttps://doi.org/10.1016/j.mam.2022.101151openalex-snapshot
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
inferred← citeshttps://doi.org/10.1016/j.virusres.2023.199164openalex-snapshot
Anthracyclines inhibit SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1021/acsabm.4c01012openalex-snapshot
Glycocalyx Interactions Modulate the Cellular Uptake of Albumin-Coated Nanoparticles
inferred← citeshttps://doi.org/10.1021/acsnano.5c19714openalex-snapshot
Heparin-Binding Proteins in the Nanoparticle Corona Enhance Cellular Uptake through Glycocalyx Interactions
inferred← citeshttps://doi.org/10.1038/s41467-023-41453-wopenalex-snapshot
Host heparan sulfate promotes ACE2 super-cluster assembly and enhances SARS-CoV-2-associated syncytium formation
inferred← citeshttps://doi.org/10.1080/21505594.2026.2614154openalex-snapshot
The essential role of heparan sulfate in the entry of PDCoV and other porcine coronaviruses
inferred← citeshttps://doi.org/10.1128/mmbr.00260-24openalex-snapshot
Molecular mechanisms of SARS-CoV-2 entry: implications for biomedical strategies
inferred← citeshttps://doi.org/10.1134/s0006350925700472openalex-snapshot
Molecular Dynamics Modeling of Pharmacological Vector-Receptor Pairs for Specific Drug Delivery to the Tumor: Atomic/Molecular Mechanisms of RGD Peptide Embedding in the Integrin αvβ3 Receptor
inferred← citeshttps://doi.org/10.1186/s13065-025-01689-7openalex-snapshot
Mechanism-informed identification of FDA-approved topoisomerase inhibitors disrupting SARS-CoV-2 nucleocapsid–RNA interactions
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3972887/v1openalex-snapshot
Drug-loaded MITO@HA nanodrugs for evaluating the efficacy of targeted therapy for pancreatic cancer
inferred← citeshttps://doi.org/10.30895/1991-2919-2023-564openalex-snapshot
Analysis of Requirements for Inhalation Toxicity Studies of Chemicals
inferred← citeshttps://doi.org/10.3389/fmed.2024.1364657openalex-snapshot
Therapeutic development targeting host heparan sulfate proteoglycan in SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.3389/fphar.2025.1537912openalex-snapshot
FDA-approved drug repurposing screen identifies inhibitors of SARS-CoV-2 pseudovirus entry
inferred← citeshttps://doi.org/10.3390/cimb48040411openalex-snapshot
MD Simulation of Vector–Receptor Pharmacologic Pairs for Tumor-Specific Drug Delivery: Transfer of Boron Atoms by RGD Peptide to αvβ3 Integrin Receptor
inferred← citeshttps://doi.org/10.3390/ijms24098327openalex-snapshot
In Vitro and In Vivo Therapeutic Potential of 6,6′-Dihydroxythiobinupharidine (DTBN) from Nuphar lutea on Cells and K18-hACE2 Mice Infected with SARS-CoV-2
inferred← citeshttps://doi.org/10.4236/ampc.2025.152002openalex-snapshot
MD Modeling of Pharmacological Vector-Receptor Pairs for Specific Drug Delivery to the Tumor: Atomic/Molecular Mechanisms of RGD-Peptide Embedding in the αvβ3-Integrin Receptor
inferred← citeshttps://doi.org/10.5204/thesis.eprints.246091openalex-snapshot
Molecular recognition of anion binding proteins: Characterization and inhibition
inferred← citeshttps://doi.org/10.5603/pjnns.a2023.0014openalex-snapshot
Blood-brain barrier function in response to SARS-CoV-2 and its spike protein
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.